德展健康(000813.SZ):控股股東通過大宗交易和協議轉讓方式減持3.535%股份
格隆匯7月3日丨德展健康(000813.SZ)公佈,公司於2020年7月3日收到公司控股股東美林控股的告知函,獲悉美林控股已於2020年7月1日辦理完成與申萬宏源證券有限公司(作為證券行業支持民企發展之申萬宏源2號單一資產管理計劃管理人)股份協議轉讓的登記過户手續,美林控股從2020年3月1日-7月2日通過大宗交易和協議轉讓方式共計轉讓公司股份7922.8268萬股,佔公司總股本的3.535%。
截止公告日,美林控股共計持有公司股份6.4205億股,佔公司總股本的28.64%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.